727 related articles for article (PubMed ID: 30952553)
21. Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted
Rudolph ME; McArthur MA; Magder LS; Barnes RS; Chen WH; Sztein MB
Front Immunol; 2019; 10():257. PubMed ID: 30886613
[TBL] [Abstract][Full Text] [Related]
22. Improving Our Understanding of
Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
[TBL] [Abstract][Full Text] [Related]
23. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.
Wahid R; Zafar SJ; McArthur MA; Pasetti MF; Levine MM; Sztein MB
Clin Vaccine Immunol; 2014 Mar; 21(3):427-34. PubMed ID: 24429069
[TBL] [Abstract][Full Text] [Related]
24. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
[TBL] [Abstract][Full Text] [Related]
25. Serodiagnosis of Salmonella enterica serovar Typhi and S. enterica serovars Paratyphi A, B and C human infections.
Chart H; Cheasty T; de Pinna E; Siorvanes L; Wain J; Alam D; Nizami Q; Bhutta Z; Threlfall EJ
J Med Microbiol; 2007 Sep; 56(Pt 9):1161-1166. PubMed ID: 17761477
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Wang JY; Noriega FR; Galen JE; Barry E; Levine MM
Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
[TBL] [Abstract][Full Text] [Related]
27. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
Pakkanen SH; Kantele JM; Kantele A
Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
[TBL] [Abstract][Full Text] [Related]
29. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
30. Vaccine value profile for Salmonella enterica serovar Paratyphi A.
Martin LB; Khanam F; Qadri F; Khalil I; Sikorski MJ; Baker S
Vaccine; 2023 Nov; 41 Suppl 2():S114-S133. PubMed ID: 37951691
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
32. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
[TBL] [Abstract][Full Text] [Related]
33. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
[TBL] [Abstract][Full Text] [Related]
34. Differential functional patterns of memory CD4
Salerno-Gonçalves R; Tettelin H; Luo D; Guo Q; Ardito MT; Martin WD; De Groot AS; Sztein MB
Vaccine; 2020 Jan; 38(2):258-270. PubMed ID: 31629569
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
Gibani MM; Voysey M; Jin C; Jones C; Thomaides-Brears H; Jones E; Baker P; Morgan M; Simmons A; Gordon MA; Cerundolo V; Pitzer VE; Angus B; Levine MM; Darton TC; Pollard AJ
Clin Infect Dis; 2019 Apr; 68(8):1265-1273. PubMed ID: 30252031
[TBL] [Abstract][Full Text] [Related]
36. IgA and IgG1 Specific to Vi Polysaccharide of
Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
Front Immunol; 2019; 10():2582. PubMed ID: 31781100
[TBL] [Abstract][Full Text] [Related]
37. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
38. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal
Haldar R; Dhar A; Ganguli D; Chakraborty S; Pal A; Banik G; Miyoshi SI; Das S
Front Immunol; 2023; 14():1304170. PubMed ID: 38264668
[TBL] [Abstract][Full Text] [Related]
39. Enteric fever due to Salmonella typhi and paratyphi A a neglected and emerging problem.
Wilde H
Vaccine; 2007 Jul; 25(29):5246-7. PubMed ID: 17560692
[No Abstract] [Full Text] [Related]
40. Enteric fever and its impact on returning travellers.
Dave J; Sefton A
Int Health; 2015 May; 7(3):163-8. PubMed ID: 25808163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
